We have identified a component of about 35 kDa (pp35), present in human placental membrane preparations, that is a substrate for epidermal growth factor (urogastrone) [EGF(Uro)]-mediated phosphorylation. The EGF(Uro)-stimulated phosphorylation of pp35 was calciumdependent and was markedly enhanced in membranes prepared in the presence (but not in the absence) of calcium. The phosphate incorporated into pp35 in the presence of EGF(Uro) was alkali-stable and was present as 04-phosphotyrosine. 
cental membranes or solubilized EGF(Uro) receptor immobilized on concanavalin A-agarose. In contrast, the addition of (3 subunits derived from rabbit liver GI or bovine transducin did not result in phosphorylation of a 35-kDa substrate in the reconstituted system. Further, a 35-kDa protein released from placental membranes crossreacted with an anti-transducin antibody that can recognize the (3 subunit isolated from a variety of sources. We conclude that the human placental pp35 substrate likely represents the placental equivalent of the protein. Our data point to a possible link between those receptors involved in growth-factor action and the regulatory systems that utilize GTP-binding proteins as transducing elements.
The receptors for growth factors such as insulin, epidermal growth factor (urogastrone) [EGF(Uro)], and platelet-derived growth factor are ligand-regulated, tyrosine-specific protein kinases. There is intense interest in identifying cellular substrates for the receptor kinases, because such substrates may play an important role in the actions of these growth factors (1) (2) (3) (4) . The work described in this report was stimulated by the hypothesis that a guanine nucleotide regulatory complex (G or N proteins; see refs. 5 and 6) might serve as a target for the EGF(Uro) receptor kinase.
Guanine nucleotide regulatory complexes play a key role in the stimulation (Gj) and inhibition (G) of adenylate cyclase.
Analogous complexes belonging to this family of G-protein complexes appear to comprise oligomeric structures of general composition af3y where the a (and perhaps the y) polypeptides are distinct for each complex, whereas the 35-kDa 13 subunit is a common constituent. In these systems the release of an activated form of the a subunits is thought to be the receptor-regulated process triggering cellular biochemical response(s) (5-7). The common 3-y subunit from rabbit liver Gi and G, has been shown to inhibit adenylate cyclase and to function as a competitor for added G, and G; a subunit (8, 9) . Since the 3-y subunits isolated from rabbit liver G, and Gi and from bovine transducin are all functionally interchangeable (J.K.N., unpublished observations), we hypothesized that regulation of cyclic AMP levels might occur through the additional mechanism of modification of (3- Isolation of EGF(Uro). Mouse EGF(Uro) was isolated from male mouse submaxillary glands, as described (11) .
Isolation of G Proteins and (3 Subunits. Rabbit liver Gi was isolated essentially as described (12), with minor modifications leading to the isolation of an additional fraction of 3 subunit used in these studies. Four independent rabbit liver membrane preparations were extracted and purified by chromatography on DEAE and AcA 34 columns as described (12) . The Gi-containing fractions from the AcA 34 columns were pooled and rechromatographed on AcA 34 prior to hydrophobic chromatography on heptylamine-Sepharose.
The latter chromatography resolved G5, Gi, and a free 35-kDa protein (/3-35; Elaine Fraser and J.K.N., unpublished work) used in these experiments. /-35 appears closely related to the /3 subunit of G, and Gi, as judged by peptide mapping after limited proteolysis; the preparation also contains ,3-subunit activity in that it can reverse fluoride-activated G, a subunit (13) . The intrinsic activity of ,-35 against G, is about one-tenth that of 3-yisolated from rabbit liver Gi. In addition, antisera raised against transducin /3 subunit preferentially crossreact with the common 83 subunit of rabbit liver G, and Gi, as compared with the rabbit liver 3-35. Thus, /3-35 is related to but distinct from the G, and Gi /3 subunit.
Bovine retinal rod transducin was prepared essentially as described (14) except that all procedures were performed under normal illumination.
Subunits of G proteins were isolated by the HPLC procedure described for G, (15 (Fig. 1, lane 3) , whereas in EDTA/EGTA-prepared membranes, EGF(Uro)-stimulated phosphorylation of pp35 was barely detectable (Fig. 1, lane 5) . In contrast, EGF(Uro)-stimulated autophosphorylation of the receptor itself was apparent for membranes prepared under either set of conditions (Fig. 1, lanes 1, 3, Ca2l in the assay medium (Fig. 1, lanes 3 and 4) . Further, once phosphorylated, pp35 could be released from the membranes by EGTA treatment (Fig. 2) ; :40% of the radioactivity that migrates in the 35-kDa region of the gel was released into the supernatant. This procedure also released a 35-kDa protein(s) that crossreacted with anti-transducin antibody (Fig. 2, (Fig. 3, lane 5) . In a similar experiment, wherein purified rabbit liver P-35 protein was added to a phosphorylation mixture containing EDTA/EGTA-membranes, EGF(Uro) was able to stimulate the phosphorylation of a 35-kDa component (presumably, added f-35) (Fig. 3,   lane a) . Phosphorylation was not observed on addition of oligomeric transducin or Gi or their isolated 3-y subunits.
Presumably, whatever the chemical differences are between (335 and the common subunit of Gs and Gi or transducin determine its ability to serve as a substrate for the EGF(Uro) receptor kinase. Because the rabbit liver -35 preparation contained detergent that interfered with the phosphorylation assay, it was not possible to evaluate with confidence the stoichiometry of phosphorylation. In a separate experiment, EGF(Uro)-stimulated phosphorylation of added 335 was observed when the assay was done using solubilized (Triton X-100) receptor that had been washed and immobilized on concanavalin A-agarose (data not shown). Because of the uncertainty with respect to the stoichiometry of phosphorylation and because the method of membrane preparation inactivated hormone-stimulated adenylate cyclase, we have as yet been unable to examine directly the consequence of pp35 phosphorylation on its ability to regulate adenylate cyclase.
Immunological Detection of Subunit in Placental Membranes. Proteins in the Ca2+/iodoacetate membrane preparation were eluted with 5 mM EGTA and protein in the clarified supernatant (200,000 x g for 60 min at 4°C) was concentrated by precipitation with trichloroacetic acid. Immunoblot analysis following electrophoresis revealed the presence of a placental 35-kDa constituent that crossreacted with anti-transducin antibody (Fig. 2) . This antiserum recognized all three subunits of transducin on immunoblots but only recognized the 8 subunit of purified Gs and Gi proteins from rabbit liver. Antisera prepared against purified ,8 subunit from transducin or from human placental Gi recognized only shown). As yet, we have been unable to develop a suitable immunoprecipitation assay for the P-subunit proteins.
DISCUSSION
Our results indicate (i) that in human placental membranes prepared in the presence of Ca2", EGF(Uro) stimulates the phosphorylation of a 35-kDa substrate in a Ca2"-dependent fashion; (ii) that in membranes depleted of the 35-kDa substrate, EGF(Uro) is able to stimulate the phosphorylation of added ,B-35 protein isolated from rabbit liver; and (iii) that placental membranes isolated in the presence of Ca2" contain a 35-kDa protein that can be released from the membranes by EGTA and that crossreacts with antisera that can recognize G-protein P subunit derived from a number of sources. Taken together, our data suggest that it is the placental 1-35 protein that serves as a substrate for the EGF(Uro)-stimulated phosphorylation reaction. An alternative but less likely interpretation of our data is that the 13-35 (either present in the placental membranes or added back to the membrane preparation) is required for EGF(Uro)-stimulated phosphorylation of a second 35-kDa constituent that comigrates in the electrophoretic gels. Further work (e.g., proteolytic mapping) will be necessary to disprove unequivocally this alternative interpretation of the data.
Our results point to an interesting potential link between tyrosine kinase receptors involved in growth-factor action and the hormonal systems mediated by GTP-binding proteins. Since the subunit plays a critical role in the inhibition of adenylate cyclase, it will, in the light of our observations, be of importance to evaluate the effect of phosphorylation on the activity of P-35. An esterase (7) and possibly phospholipase C (18), the 13-35 phosphorylation state could potentially regulate a number of enzyme activities apart from adenylate cyclase.
Our results single out the subunit for attention in this regard, since the a subunits of the G-protein complex, which were also present in the placental membrane preparation, did not exhibit increased phosphorylation in the presence of EGF(Uro). Neither were the a subunits of pure Gi or of transducin phosphorylated when added to the EGTA-depleted membrane reconstitution system. The inability of insulin to stimulate pp35 phosphorylation under identical conditions may suggest some receptor specificity in terms of the phosphorylation of membrane substrates by different receptor kinases.
Our results may bear directly on information that appeared in the course of our work, describing the isolation from A431 cells of a 35-kDa substrate for the EGF(Uro) receptor kinase (19) . Like the placental pp35 we describe, the 35-kDa substrate described by Fava and Cohen (19) bound in a Ca2"-dependent manner to A431 membranes and required Ca2" in the reaction medium for the detection of substrate phosphorylation. However, in contrast with our results with placental membranes, in order to detect EGF(Uro)-stimulated phosphorylation of the 35-kDa A431-cell substrate, it was necessary to expose intact A431 cells to EGF(Uro) prior to the membrane isolation procedure. Nonetheless, once isolated, the 35-kDa substrate from A431 cells could serve as substrate for the EGF(Uro) receptor kinase in a reconstituted system. The 35-kDa substrate from A431-cell membranes appeared to differ from other potential EGF(Uro) receptor substrate(s) of comparable molecular mass (34-39 kDa) that have been detected in 32P-labeled cells after Rous sarcoma virus infection (19) (20) (21) (22) (23) (24) (25) (26) (27) and that have been isolated from intestinal epithelium (28) . The relationships of the 35-kDa A431 substrate (19) and the 36-kDa intestinal substrate (28) to the G-protein f subunit remain to be determined.
